Feasibility of time-restricted eating in individuals with overweight, obesity, prediabetes, or type 2 diabetes: A systematic scoping review
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Feasibility of time-restricted eating in individuals with overweight, obesity, prediabetes, or type 2 diabetes : A systematic scoping review. / Termannsen, Anne Ditte; Varming, Annemarie; van Elst, Christina; Bjerre, Natasja; Nørgaard, Ole; Hempler, Nana Folmann; Færch, Kristine; Quist, Jonas Salling.
I: Obesity, Bind 31, Nr. 6, 2023, s. 1463-1485.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Feasibility of time-restricted eating in individuals with overweight, obesity, prediabetes, or type 2 diabetes
T2 - A systematic scoping review
AU - Termannsen, Anne Ditte
AU - Varming, Annemarie
AU - van Elst, Christina
AU - Bjerre, Natasja
AU - Nørgaard, Ole
AU - Hempler, Nana Folmann
AU - Færch, Kristine
AU - Quist, Jonas Salling
N1 - Publisher Copyright: © 2023 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society.
PY - 2023
Y1 - 2023
N2 - Objective: This systematic scoping review aimed to map and synthesize research on feasibility of time-restricted eating (TRE) in individuals with overweight, obesity, prediabetes, or type 2 diabetes, including recruitment rate, retention rate, safety, adherence, and participants' attitudes, experiences, and perspectives. Methods: The authors searched MEDLINE, Embase, and Cumulative Index to Nursing and Allied Health Literature from inception to November 22, 2022, supplemented by backward and forward citation search. Results: From 4219 identified records, 28 studies were included. In general, recruitment was easy and median retention rate was 95% among studies with <12 weeks duration and 89% among studies ≥12 weeks. Median (range) adherence to the target eating window for studies <12 and ≥12 weeks was 89% (75%–98%) and 81% (47%–93%), respectively. Variation in adherence among participants and studies was considerable, indicating that following TRE was difficult for some people and that intervention conditions influenced adherence. These findings were supported by qualitative data synthetized from seven studies, and determinants of adherence included calorie-free beverages outside the eating window, provision of support, and influence on the eating window. No serious adverse events were reported. Conclusions: TRE is implementable, acceptable, and safe in populations with overweight, obesity, prediabetes, or type 2 diabetes, but it should be accompanied by support and options for individual adjustments.
AB - Objective: This systematic scoping review aimed to map and synthesize research on feasibility of time-restricted eating (TRE) in individuals with overweight, obesity, prediabetes, or type 2 diabetes, including recruitment rate, retention rate, safety, adherence, and participants' attitudes, experiences, and perspectives. Methods: The authors searched MEDLINE, Embase, and Cumulative Index to Nursing and Allied Health Literature from inception to November 22, 2022, supplemented by backward and forward citation search. Results: From 4219 identified records, 28 studies were included. In general, recruitment was easy and median retention rate was 95% among studies with <12 weeks duration and 89% among studies ≥12 weeks. Median (range) adherence to the target eating window for studies <12 and ≥12 weeks was 89% (75%–98%) and 81% (47%–93%), respectively. Variation in adherence among participants and studies was considerable, indicating that following TRE was difficult for some people and that intervention conditions influenced adherence. These findings were supported by qualitative data synthetized from seven studies, and determinants of adherence included calorie-free beverages outside the eating window, provision of support, and influence on the eating window. No serious adverse events were reported. Conclusions: TRE is implementable, acceptable, and safe in populations with overweight, obesity, prediabetes, or type 2 diabetes, but it should be accompanied by support and options for individual adjustments.
UR - http://www.scopus.com/inward/record.url?scp=85159881192&partnerID=8YFLogxK
U2 - 10.1002/oby.23743
DO - 10.1002/oby.23743
M3 - Review
C2 - 37203334
AN - SCOPUS:85159881192
VL - 31
SP - 1463
EP - 1485
JO - Obesity
JF - Obesity
SN - 1930-7381
IS - 6
ER -
ID: 350894175